… Because Cd was previously shown to induce ROS accumulation in various cells, we therefore
investigated its effect on ROS production in HT-29 colon cancer cells. As shown in Fig. 2C …

… Purpose: To explore the effects of atorvastatin (ATST) on the proliferation and apoptosis
of colon cancer cells through the cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2)/βcatenin …

… play vital roles in regulating cancer development and progression. … in different types of cancer.
Understanding the regulatory … Colorectal cancer (CRC) is one of the most common human …

… the risk of developing colon cancer and resulted in reduced multiplicity of distal colon tumors
as … the development of colon cancer (21). Taken together, PGE2 is essential in the growth of …

… Colorectal cancer (CRC) is the third leading cause of cancer-related death in both men
and women in the United States and also one of the most preventable malignancies. (1,2) …

… trials of low-dose aspirin and selective cyclooxygenase-2 inhibitors. A single placebo-… term
colorectal cancer prevention in patients with the Lynch syndrome. The sequential involvement …

… of the cyclooxygenase-2–prostaglandin E 2 pathway on gastrointestinal cancer development.
… For example, colorectal cancer (CRC) is the fourth most common malignancy and the third …

… colorectal cancer and showed reduction of colon cancer stem cell subpopulation and tumor
growth, thus confirming their impairment of the EGFR/RAS/FOXM1/β-catenin signaling axis. …

… We analyzed the in vitro proliferative and secretory responses of murine C26 colorectal
cancer (CRC) cells to soluble ICAM-1 (sICAM-1), cultured alone or with LSECs, and their effect …

… as a molecular marker and a potential therapeutic target is cyclooxygenase-2 (Cox-2) in
various cancers. The main function of Cox is to synthesize prostaglandins (PGs) from …